Relationship Between Pre-induction Electroencephalogram Pattern of Adult Patients and Their Sensitivity to Propofol
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Aug 17, 2020
Trial Information
Current as of September 07, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients undergoing general anesthesia
- Exclusion Criteria:
- • Patients undergoing cardiac or brain surgery
- • Patients with neurological deficit or impaired communication (Glasgow Coma Scale \< 15)
- • Unstable vital sign (cardiogenic, hemorrhagic, septic shock)
- • Patients with eclampsia
- • Patients who administered preoperative anxiolytics
- • Patients who do not require intubation
- • Patients who are considered unsuitable for the study
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Jin-Tae Kim, PhD
Principal Investigator
Seoul National University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials